Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

MYSTERIOUS: Eric topol - What They Never Told You

FDA to discuss easing restrictions on peptides despite safety concerns

Committee will meet in July to discuss peptides now sold in gray market despite limited evidence of safety and efficacy

The Guardian - US

RFK Jr.'s peptide push could become next wellness boom

The heavily touted but loosely regulated proteins could fuel the kind of boom we've seen with weight-loss drugs.

Axios

Americans are injecting themselves with unproven peptides sold by influencers and RFK Jr. allies

More Americans are turning to peptides for muscle building, skin rejuvenation, and to try and live longer even though the substances aren’t FDA approved

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

3 takeaways from a cardiologist and 'SuperAgers' researcher on how to live longer and healthier

Dr. Eric Topol says science can make “big inroads by preventing age-related diseases.”

Fortune

Cardiologist Dr Eric Topol's daily routine: 5:30am starts and not a bite of red meat for 40 years

The US cardiologist cracks on with research at 5.30am, always makes time for exercise and relies on an Oura ring for his deep sleep

Evening Standard

3 takeaways from a cardiologist and 'SuperAgers' researcher on how to live longer and healthier

Dr. Eric Topol says science can make “big inroads by preventing age-related diseases.”

Fortune

The startup founded by Coinbase's CEO raised $130 million by claiming aging is malleable. Does science back it up?

Experts in aging weigh in.

Fortune

Read news from The Economist, FT, and more,
with one subscription

‘Get rid of the pseudoscience’: top doctor’s plan to improve America’s health

Eric Topol says we can prevent age-related disease and live fuller lives – but only if we reject anti-science ‘malarkey’

The Guardian - US

Woman’s diabetes reversed after world-first stem cell transplant

Researchers report ‘no indication of abnormalities’ and ‘functional reversal’ of patient’s diabetes a year after procedure

The Independent UK

Will the XEC COVID subvariant bring a fall wave of infections? What to know about symptoms and spread

The U.S. is coming down from its biggest COVID summer surge yet as a new subvariant emerges—but new vaccines are here, too.

Fortune

New Covid XEC variant starting to spread in Europe – what we know about signs and symptoms

More contagious virus is sublineage of omicron variant, scientists say

The Independent UK

Long COVID is still a problem, racking up a global cost of $1 trillion

Experts want government agencies to act.

Fortune

Highly mutated COVID variant ‘Pirola’ JN.1 is fueling the pandemic’s second highest U.S. wave—and it’s still growing

Fortune

Why hasn't the WHO assigned a Greek letter to JN.1 "Pirola"? How it decides when to name COVID-19 variants

In an exclusive interview with Fortune, the WHO's COVID-19 lead said the organization is ready to assign a new Greek letter on a moment’s notice, but is holding out for a variant that's "truly different." Not all experts agree with the approach.

Fortune

Get all your
news in one place.

100's of premium titles.
One news app.

WEKU

For the first time, gene-editing provides hints for lowering cholesterol

Researchers report the first results from a study testing the revolutionary gene-editing technique known as CRISPR for cutting high cholesterol.

Fortune

COVID levels are so high, they're approaching 2020's initial peak, as the WHO urges those at high risk to take any booster they can get their hands on

It’s yet another sign that while the official pandemic state may be over, the days of COVID are far from it.

The Week

Covid-19: where we are now

An increase in Covid cases over the summer, driven by new Omicron variants, has led scientists to warn that the world is vulnerable to a new wave of infections.

Fortune

Long COVID. Shorter Life? New research reveals an arduous road to recovery

The first study to look at two years of data shows the devastating effects of long COVID-but there are still no validated treatments.

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

With ‘Eris’ rising and now ‘Fornax,’ when are COVID cases likely to peak again? A look at what may lie ahead for fall and winter

Expect peaks this fall and winter not as much as a high wall of cases, experts say.

Fortune

WHO designates ‘Eris' and related COVID strains as variants of interest as infections and hospitalizations tick upward

Plus, a look ahead at what’s likely to come this fall and winter: ‘My best guess is we're heading back up to a high baseline’ of cases, one expert tells Fortune.

WEKU

You know those folks who had COVID but no symptoms? A new study offers an explanation

Everybody knows someone — maybe it's you — who got COVID but never got sick or who thinks they never got COVID at all. A new study found one possible reason, involving a certain gene and common colds.

Salon

Are healthcare workers ready to unmask?

Should your doctor still wear a mask? Not all medical experts agree

Salon

The CDC has stopped tracking COVID cases

Some experts worry this move will hinder public health in the event of a future infectious mutation

Los Angeles Times

Fatigue, cough and brain fog. For many in LA County, long COVID limited daily life

Most Los Angeles County residents who have been afflicted with long COVID reported experiencing symptoms severe enough to limit their daily activities for more than four weeks after they became infected, according to a recent survey.

The Independent UK

Pandemic 3 years later: Has the COVID-19 virus won?

It’s been three years since the World Health Organization's first called COVID-19 a pandemic on March 11, 2020

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.